| pubmed-article:15160353 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C0348026 | lld:lifeskim |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C0746883 | lld:lifeskim |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C1514475 | lld:lifeskim |
| pubmed-article:15160353 | lifeskim:mentions | umls-concept:C0072027 | lld:lifeskim |
| pubmed-article:15160353 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:15160353 | pubmed:dateCreated | 2004-5-25 | lld:pubmed |
| pubmed-article:15160353 | pubmed:abstractText | Cancer patients with fever and neutropenia currently are assessed on clinical grounds only. The current study prospectively evaluated the efficacy of baseline procalcitonin (PCT) in the detection of bacteremia and in the prediction of outcome in patients with solid tumors and febrile neutropenia. | lld:pubmed |
| pubmed-article:15160353 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15160353 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15160353 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15160353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15160353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15160353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15160353 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15160353 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15160353 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15160353 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:Paz-AresLuisL | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:Cortés-FunesH... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:JimenoAntonio... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:DuránIgnacioI | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:García-Velasc... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:del ValOlgaO | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:González-Bill... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:HernandoSusan... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:HernándezRosa... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:Sánchez-Muñoz... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:López-MartínA... | lld:pubmed |
| pubmed-article:15160353 | pubmed:author | pubmed-author:RoblesLuisL | lld:pubmed |
| pubmed-article:15160353 | pubmed:copyrightInfo | Copyright 2004 American Cancer Society. | lld:pubmed |
| pubmed-article:15160353 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15160353 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15160353 | pubmed:volume | 100 | lld:pubmed |
| pubmed-article:15160353 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15160353 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15160353 | pubmed:pagination | 2462-9 | lld:pubmed |
| pubmed-article:15160353 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:meshHeading | pubmed-meshheading:15160353... | lld:pubmed |
| pubmed-article:15160353 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15160353 | pubmed:articleTitle | Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. | lld:pubmed |
| pubmed-article:15160353 | pubmed:affiliation | Division of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. | lld:pubmed |
| pubmed-article:15160353 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15160353 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15160353 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15160353 | lld:pubmed |
